161 related articles for article (PubMed ID: 20946663)
1. Treatment combining RU486 and Ad5IL-12 vector attenuates the growth of experimentally formed prostate tumors and induces changes in the sentinel lymph nodes of mice.
Gabaglia CR; DeLaney A; Gee J; Halder R; Graham FL; Gauldie J; Sercarz EE; Braciak TA
J Transl Med; 2010 Oct; 8():98. PubMed ID: 20946663
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the glucocorticoid response during Ad5IL-12 adenovirus vector treatment enhances natural killer cell-mediated killing of MHC class I-negative LNCaP prostate tumors.
Raja Gabaglia C; Diaz de Durana Y; Graham FL; Gauldie J; Sercarz EE; Braciak TA
Cancer Res; 2007 Mar; 67(5):2290-7. PubMed ID: 17332360
[TBL] [Abstract][Full Text] [Related]
3. [Construction of a RU486 inducible recombinant adenoviral vector carrying murine interleukin-12 gene and experimental treatment of colonic carcinoma].
Chen J; Liu XS; Wang F; Xue XC; Fang GE; Su CQ; Qian QJ
Zhonghua Yi Xue Za Zhi; 2009 May; 89(20):1372-6. PubMed ID: 19671324
[TBL] [Abstract][Full Text] [Related]
4. A single intramuscular injection with an adenovirus-expressing IL-12 protects BALB/c mice against Leishmania major infection, while treatment with an IL-4-expressing vector increases disease susceptibility in B10.D2 mice.
Gabaglia CR; Pedersen B; Hitt M; Burdin N; Sercarz EE; Graham FL; Gauldie J; Braciak TA
J Immunol; 1999 Jan; 162(2):753-60. PubMed ID: 9916695
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model.
Nasu Y; Bangma CH; Hull GW; Lee HM; Hu J; Wang J; McCurdy MA; Shimura S; Yang G; Timme TL; Thompson TC
Gene Ther; 1999 Mar; 6(3):338-49. PubMed ID: 10435084
[TBL] [Abstract][Full Text] [Related]
6. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
[TBL] [Abstract][Full Text] [Related]
7. Prolonged and inducible transgene expression in the liver using gutless adenovirus: a potential therapy for liver cancer.
Wang L; Hernández-Alcoceba R; Shankar V; Zabala M; Kochanek S; Sangro B; Kramer MG; Prieto J; Qian C
Gastroenterology; 2004 Jan; 126(1):278-89. PubMed ID: 14699506
[TBL] [Abstract][Full Text] [Related]
8. Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.
Mett V; Komarova EA; Greene K; Bespalov I; Brackett C; Gillard B; Gleiberman AS; Toshkov IA; Aygün-Sunar S; Johnson C; Karasik E; Bapardekar-Nair M; Kurnasov OV; Osterman AL; Stanhope-Baker PS; Morrison C; Moser MT; Foster BA; Gudkov AV
Oncogene; 2018 Jan; 37(4):439-449. PubMed ID: 28967901
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated CD40 ligand therapy induces tumor cell apoptosis and systemic immunity in the TRAMP-C2 mouse prostate cancer model.
Dzojic H; Loskog A; Tötterman TH; Essand M
Prostate; 2006 Jun; 66(8):831-8. PubMed ID: 16491482
[TBL] [Abstract][Full Text] [Related]
10. Effect of canarypox virus (ALVAC)-mediated cytokine expression on murine prostate tumor growth.
Kawakita M; Rao GS; Ritchey JK; Ornstein DK; Hudson MA; Tartaglia J; Paoletti E; Humphrey PA; Harmon TJ; Ratliff TL
J Natl Cancer Inst; 1997 Mar; 89(6):428-36. PubMed ID: 9091644
[TBL] [Abstract][Full Text] [Related]
11. Macrophages transduced with an adenoviral vector expressing interleukin 12 suppress tumor growth and metastasis in a preclinical metastatic prostate cancer model.
Satoh T; Saika T; Ebara S; Kusaka N; Timme TL; Yang G; Wang J; Mouraviev V; Cao G; Fattah el MA; Thompson TC
Cancer Res; 2003 Nov; 63(22):7853-60. PubMed ID: 14633713
[TBL] [Abstract][Full Text] [Related]
12. Replication-competent Ad11p vector (RCAd11p) efficiently transduces and replicates in hormone-refractory metastatic prostate cancer cells.
Sandberg L; Papareddy P; Silver J; Bergh A; Mei YF
Hum Gene Ther; 2009 Apr; 20(4):361-73. PubMed ID: 19199789
[TBL] [Abstract][Full Text] [Related]
13. Versatile prostate cancer treatment with inducible caspase and interleukin-12.
Nikitina EY; Desai SA; Zhao X; Song W; Luo AZ; Gangula RD; Slawin KM; Spencer DM
Cancer Res; 2005 May; 65(10):4309-19. PubMed ID: 15899823
[TBL] [Abstract][Full Text] [Related]
14. Induction of antitumor immunity by direct intratumoral injection of a recombinant adenovirus vector expressing interleukin-12.
Gambotto A; Tüting T; McVey DL; Kovesdi I; Tahara H; Lotze MT; Robbins PD
Cancer Gene Ther; 1999; 6(1):45-53. PubMed ID: 10078963
[TBL] [Abstract][Full Text] [Related]
15. IFN-gamma sensitization of prostate cancer cells to Fas-mediated death: a gene therapy approach.
Selleck WA; Canfield SE; Hassen WA; Meseck M; Kuzmin AI; Eisensmith RC; Chen SH; Hall SJ
Mol Ther; 2003 Feb; 7(2):185-92. PubMed ID: 12597906
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus E2F1 overexpression sensitizes LNCaP and PC3 prostate tumor cells to radiation in vivo.
Udayakumar TS; Stoyanova R; Hachem P; Ahmed MM; Pollack A
Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):549-58. PubMed ID: 21195876
[TBL] [Abstract][Full Text] [Related]
17. Cooperative effects of adenoviral vector-mediated interleukin 12 gene therapy with radiotherapy in a preclinical model of metastatic prostate cancer.
Fujita T; Timme TL; Tabata K; Naruishi K; Kusaka N; Watanabe M; Abdelfattah E; Zhu JX; Ren C; Ren C; Yang G; Goltsov A; Wang H; Vlachaki MT; Teh BS; Butler EB; Thompson TC
Gene Ther; 2007 Feb; 14(3):227-36. PubMed ID: 17024109
[TBL] [Abstract][Full Text] [Related]
18. Immunization with type 5 adenovirus recombinant for a tumor antigen in combination with recombinant canarypox virus (ALVAC) cytokine gene delivery induces destruction of established prostate tumors.
Elzey BD; Siemens DR; Ratliff TL; Lubaroff DM
Int J Cancer; 2001 Dec; 94(6):842-9. PubMed ID: 11745487
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines.
Hull GW; Mccurdy MA; Nasu Y; Bangma CH; Yang G; Shimura S; Lee HM; Wang J; Albani J; Ebara S; Sato T; Timme TL; Thompson TC
Clin Cancer Res; 2000 Oct; 6(10):4101-9. PubMed ID: 11051263
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer.
Shariat SF; Desai S; Song W; Khan T; Zhao J; Nguyen C; Foster BA; Greenberg N; Spencer DM; Slawin KM
Cancer Res; 2001 Mar; 61(6):2562-71. PubMed ID: 11289132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
